{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:43:49Z","timestamp":1770331429172,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","award":["grant numbers 16\/11\/00420 and 16\/11\/00403"],"award-info":[{"award-number":["grant numbers 16\/11\/00420 and 16\/11\/00403"]}],"id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Unidad de Investigaci\u00f3n Cl\u00ednica y Ensayos Cl\u00ednicos INCLIVA Health Research Institute, Spanish Clinical Research Network","award":["SCReN; PT13\/0002\/0031 and PT17\/0017\/0003"],"award-info":[{"award-number":["SCReN; PT13\/0002\/0031 and PT17\/0017\/0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35632-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:04:39Z","timestamp":1768205079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure"],"prefix":"10.1038","volume":"16","author":[{"given":"Anna","family":"Mollar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Garc\u00eda-Conejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Revuelta-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Cardells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"del Canto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"de la Espriella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.","family":"Lopez-Lereu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Vicente","family":"Monmeneu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Maceira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Lakhal-Littleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleix","family":"Cases","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Bay\u00e9s-Gen\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"35632_CR1","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.jacc.2024.03.431","volume":"83","author":"B Cheema","year":"2024","unstructured":"Cheema, B., Chokshi, A., Orimoloye, O. & Ardehali, H. Intravenous iron repletion for patients with heart failure and iron deficiency. J. Am. Coll. Cardiol. 83, 2674\u20132689 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35632_CR2","volume":"12","author":"M Babikir","year":"2020","unstructured":"Babikir, M., Ahmad, R., Soliman, A., Al-Tikrity, M. & Yassin, M. A. Iron-induced thrombocytopenia: A mini-review of the literature and suggested mechanisms. Cureus 12, e10201 (2020).","journal-title":"Cureus"},{"key":"35632_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014254","volume":"9","author":"J N\u00fa\u00f1ez","year":"2020","unstructured":"N\u00fa\u00f1ez, J. et al. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: The myocardial-IRON trial. J. Am. Heart Assoc. 9, e014254 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"35632_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 24, 4\u2013131 (2022).","journal-title":"Eur. J. Heart Fail."},{"key":"35632_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/clc.22956","volume":"41","author":"G Mi\u00f1ana","year":"2018","unstructured":"Mi\u00f1ana, G. et al. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design. Clin. Cardiol. 41, 729\u2013735 (2018).","journal-title":"Clin. Cardiol."},{"key":"35632_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.004077","volume":"9","author":"A Schuster","year":"2016","unstructured":"Schuster, A., Hor, K. N., Kowallick, J. T., Beerbaum, P. & Kutty, S. Cardiovascular magnetic resonance myocardial feature tracking: Concepts and clinical applications. Circ. Cardiovasc. Imaging 9, e004077 (2016).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"35632_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022214","volume":"11","author":"I Del Canto","year":"2022","unstructured":"Del Canto, I. et al. Short-term changes in left and right ventricular cardiac magnetic resonance feature tracking strain following ferric carboxymaltose in patients with heart failure: A substudy of the Myocardial-IRON trial. J. Am. Heart Assoc. 11, e022214 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"35632_CR8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jmri.26866","volume":"5","author":"E Aherne","year":"2020","unstructured":"Aherne, E., Chow, K. & Carr, J. Cardiac T1 mapping: Techniques and applications. J. Magn. Reson. Imaging 5, 1336\u20131356 (2020).","journal-title":"J. Magn. Reson. Imaging"},{"key":"35632_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10741-017-9621-8","volume":"22","author":"A Scatteia","year":"2017","unstructured":"Scatteia, A., Baritussio, A. & Bucciarelli-Ducci, C. Strain imaging using cardiac magnetic resonance. Heart Fail. Rev. 22, 465\u2013476 (2017).","journal-title":"Heart Fail. Rev."},{"key":"35632_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/eurheartj\/ehaa587","volume":"4","author":"BP Halliday","year":"2021","unstructured":"Halliday, B. P., Senior, R. & Pennell, D. J. Assessing left ventricular systolic function: from ejection fraction to strain analysis. Eur. Heart J. 4, 789\u2013797 (2021).","journal-title":"Eur. Heart J."},{"key":"35632_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s44161-023-00352-5","volume":"2","author":"CE Angermann","year":"2023","unstructured":"Angermann, C. E. et al. Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure. Nat. Cardiovasc. Res. 2, 1032\u20131043 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"35632_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","volume":"103","author":"S Kulnigg","year":"2008","unstructured":"Kulnigg, S. et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am. J. Gastroenterol. 103, 1182\u20131192 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"35632_CR13","doi-asserted-by":"crossref","unstructured":"Evstatiev, R., et al. (2011). FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology, 141, 846\u2013853.e1\u20132.","DOI":"10.1053\/j.gastro.2011.06.005"},{"key":"35632_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jcpt.12218","volume":"40","author":"AM Hazara","year":"2015","unstructured":"Hazara, A. M. & Bhandari, S. Intravenous iron administration is associated with reduced platelet counts in patients with chronic kidney disease. J. Clin. Pharm. Ther. 40, 20\u201323 (2015).","journal-title":"J. Clin. Pharm. Ther."},{"key":"35632_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2369-15-119","volume":"15","author":"L Yessayan","year":"2014","unstructured":"Yessayan, L., Yee, J., Zasuwa, G., Frinak, S. & Besarab, A. Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study. BMC Nephrol. 15, 119 (2014).","journal-title":"BMC Nephrol."},{"key":"35632_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255104","volume":"16","author":"A Basha","year":"2021","unstructured":"Basha, A. et al. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia. PLoS ONE 16, e025510 (2021).","journal-title":"PLoS ONE"},{"key":"35632_CR17","volume":"93","author":"HA Almasri","year":"2022","unstructured":"Almasri, H. A. et al. Prevalence and significance of leukopenia induced by intravenous iron therapy in a large cohort of females with iron deficiency anemia (IDA). Acta Bio Medica Atenei Parm 93, e2022183 (2022).","journal-title":"Acta Bio Medica Atenei Parm"},{"key":"35632_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","volume":"69","author":"KA Lyseng-Williamson","year":"2009","unstructured":"Lyseng-Williamson, K. A. & Keating, G. M. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 69, 739\u2013756 (2009).","journal-title":"Drugs"},{"key":"35632_CR19","doi-asserted-by":"crossref","unstructured":"Moore, A. H. (2109). Thrombocytopenia in cirrhosis: A review of pathophysiology and management options. Clin. Liver Dis., 14, 183\u20136.","DOI":"10.1002\/cld.860"},{"key":"35632_CR20","doi-asserted-by":"crossref","unstructured":"Vera-Aviles, M., et al. (2024). Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway. Eur. Heart J., ehae359.","DOI":"10.1093\/eurheartj\/ehae359"},{"key":"35632_CR21","first-page":"475","volume":"29","author":"MG \u00c7etin\u00e7akmak","year":"2020","unstructured":"\u00c7etin\u00e7akmak, M. G. et al. Evaluation of the relationship between splenic iron overload and liver, heart and muscle features evident on T2*-weighted magnetic resonance imaging. Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ. 29, 475\u2013480 (2020).","journal-title":"Exp. Med. Off. Organ Wroclaw Med. Univ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35632-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:29:55Z","timestamp":1770287395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35632"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35632-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5044"}}